Category: Consumer goods
Quick infos Headquarters: Westlake Village, California, United States Trade prices Volume: Market Cap: 1.01B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: November 8, 2022 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast February 28, 2023 November 8, 2022 -0.06 / -0.08832.83M / 24.45MBeat! August 9, 2022 -0.11 / -0.09418.89M / 15.62MBeat! May 5, 2022 -0.1 / -0.09811.99M / 10.58MBeat! February 24, 2022 -0.11 / -0.06712.52M / 17.07Mview more
Historical Data Date Price Open High Low Vol Change ER Aug 9, 2022 4.090 4.290 4.320
4.090
4.04M -6.19% Aug 8, 2022 4.360 4.350 4.470
4.254
3.39M 0.69% Aug 5, 2022 4.330 4.210 4.387
4.160
4.23M 0.93% Aug 4, 2022 4.290 4.090 4.295
4.090
3.63M 4.63% Aug 3, 2022 4.100 4.000 4.200
4.000
4.48M 4.06% Aug 2, 2022 3.940 3.600 4.075
3.560
5.39M 10.06% Aug 1, 2022 3.580 3.450 3.810
3.420
4.26M 3.77% Jul 29, 2022 3.450 3.470 3.520
3.400
2.20M -1.43% Jul 28, 2022 3.500 3.510 3.550
3.381
2.61M 0.29% Jul 27, 2022 3.490 3.480 3.510
3.350
2.63M 1.45% view more
More profiles and info about the company News
MannKind Corporation Reports 2021 Third Quarter Financial Results finance.yahoo.com May 19, 2022 4:05 pm
MannKind Corporation Reports 2021 Second Quarter Financial Results finance.yahoo.com May 19, 2022 4:00 pm
MannKind Corporation Reports 2022 First Quarter Financial Results finance.yahoo.com May 19, 2022 4:00 pm
Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher finance.yahoo.com May 19, 2022 2:37 pm MannKind's stock falls 18% after FDA says it will not approve application for hypertension drug marketwatch.com May 19, 2022 11:42 am
FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease finance.yahoo.com May 19, 2022 8:45 am
MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension finance.yahoo.com May 19, 2022 7:26 am
MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI (aviptadil) Based On The Technosphere® Platform finance.yahoo.com May 19, 2022 6:48 am
United Therapeutics, Mannkind Fall After FDA Declines to Approve Lung Drug finance.yahoo.com May 19, 2022 6:02 am
United Therapeutics Announces FDA Acceptance of Tyvaso DPI New Drug Application For Priority Review finance.yahoo.com May 19, 2022 6:00 am
United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At The European Respiratory Society International Congress 2021 finance.yahoo.com May 19, 2022 6:00 am
Can You Imagine How Elated MannKind's (NASDAQ:MNKD) Shareholders Feel About Its 350% Share Price Gain? finance.yahoo.com May 19, 2022 4:47 am MannKind Can Climb Higher Based on Its Charts realmoney.thestreet.com May 19, 2022 4:15 am
MannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript fool.com May 19, 2022 1:01 am MannKind to acquire insulin delivery device V-Go from Zealand Pharma to bolster diabetes portfolio seekingalpha.com May 17, 2022 6:56 pm
MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand Pharma finance.yahoo.com May 17, 2022 6:06 am MannKind GAAP EPS of -$0.10 in-line, revenue of $11.99M beats by $1.38M seekingalpha.com May 6, 2022 4:03 am
MannKind Corporation (MNKD) Q1 2022 Earnings Call Transcript fool.com May 6, 2022 1:30 am MannKind Q1 2022 Earnings Preview seekingalpha.com May 5, 2022 5:35 am
Recent 11% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 85% over 3 years finance.yahoo.com Mar 3, 2022 5:25 am This company doesn't provide a dividend.
Talk about MannKind Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.mannkindcorp.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 75 HOLD 25 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!